• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌嗪结构在药物设计与发现中的不断演变的作用。

An evolving role of piperazine moieties in drug design and discovery.

机构信息

Organic Research Laboratory, Department of Bioresources and Food Science, College of Life and Environmental Sciences, Konkuk University, Seoul- 143 701, South Korea.

出版信息

Mini Rev Med Chem. 2013 Oct;13(11):1579-601. doi: 10.2174/13895575113139990073.

DOI:10.2174/13895575113139990073
PMID:23895191
Abstract

This article purposes to provide insights to piperazine based molecular designs that will facilitate drug discovery program in future. In our pursuit to summarize the reservoir of bioactive agents, and in line with the synthetic economy of new heterocycles, many new roles are being identified for the multiple biotargets of piperazine moieties. We mark out how series of different scaffolds provide an extensive range of various piperazine-based analogues displaying antimicrobial, antituberculosis, anticancer, antiviral and antimalarial activities. We believe that piperazine family of compounds, and their various co-components, highlight the existence of several potential leads for the furtherance of novel bioactive agents.

摘要

本文旨在为基于哌嗪的分子设计提供深入了解,以促进未来的药物发现计划。在我们总结生物活性物质库的过程中,并且符合新杂环的合成经济性,哌嗪部分的多个生物靶标正在被确定许多新的作用。我们指出,一系列不同的支架如何为各种显示抗菌、抗结核、抗癌、抗病毒和抗疟活性的基于哌嗪的类似物提供广泛的范围。我们相信,哌嗪类化合物及其各种共同成分突出了几个潜在的先导化合物的存在,以推进新型生物活性物质的发展。

相似文献

1
An evolving role of piperazine moieties in drug design and discovery.哌嗪结构在药物设计与发现中的不断演变的作用。
Mini Rev Med Chem. 2013 Oct;13(11):1579-601. doi: 10.2174/13895575113139990073.
2
A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.作为抗疟和抗结核药物的三取代嘧啶小型文库。
Bioorg Med Chem Lett. 2005 Dec 1;15(23):5218-21. doi: 10.1016/j.bmcl.2005.08.053. Epub 2005 Sep 19.
3
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.一些新型喹啉并1,3 - 噻嗪烷 - 4 - 酮衍生物的合成、鉴定及体外生物学评价
Bioorg Med Chem Lett. 2017 Feb 1;27(3):695-699. doi: 10.1016/j.bmcl.2016.06.038. Epub 2016 Jun 16.
4
Facile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridines.新型 1,4-二氢吡啶的简便合成及抗菌、抗结核和抗癌活性。
Arch Pharm (Weinheim). 2010 Jun;343(6):342-52. doi: 10.1002/ardp.200900243.
5
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.新型 N-芳基氨基双喹啉衍生物的合成、抗菌、抗结核和抗疟评价。
Eur J Med Chem. 2012 Aug;54:239-47. doi: 10.1016/j.ejmech.2012.05.004. Epub 2012 May 12.
6
Synthesis and biological activity of piperazine derivatives of phenothiazine.吩噻嗪哌嗪衍生物的合成及生物活性
Drug Res (Stuttg). 2015 Jan;65(1):5-8. doi: 10.1055/s-0033-1364001. Epub 2014 Jan 27.
7
Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.N1-(7-氯-4-喹啉基)-1,4-双(3-氨丙基)哌嗪衍生物的合成及其体外和体内抗疟活性
J Med Chem. 2003 Feb 13;46(4):542-57. doi: 10.1021/jm020960r.
8
EDITORIAL: New Avenues in Controlling Infectious Diseases.社论:控制传染病的新途径
Curr Top Med Chem. 2017;17(19):2113. doi: 10.2174/156802661719170616164549.
9
Synthesis, and antimalarial and antibacterial activities of marine alkaloids.海洋生物碱的合成及抗疟和抗菌活性。
Chem Biol Drug Des. 2021 Aug;98(2):226-233. doi: 10.1111/cbdd.13892. Epub 2021 Jun 4.
10
Simple isoquinoline and benzylisoquinoline alkaloids as potential antimicrobial, antimalarial, cytotoxic, and anti-HIV agents.简单异喹啉和苄基异喹啉生物碱作为潜在的抗菌、抗疟、细胞毒性和抗艾滋病毒药物。
Bioorg Med Chem. 2001 Nov;9(11):2871-84. doi: 10.1016/s0968-0896(01)00154-7.

引用本文的文献

1
Novel Hybrid Heterocycles Based on 1,4-Diphenylpiperazine Moiety: Synthesis via Hantzsch and Biginelli Reactions, Molecular Docking Simulation, and Antimicrobial Activities.基于1,4-二苯基哌嗪部分的新型杂化杂环:通过汉茨希和比吉内利反应合成、分子对接模拟及抗菌活性
ACS Omega. 2025 Aug 14;10(33):38014-38033. doi: 10.1021/acsomega.5c05245. eCollection 2025 Aug 26.
2
Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions.重新定位驱虫药用于治疗基于炎症的病理状况。
Inflammopharmacology. 2025 Feb;33(2):551-571. doi: 10.1007/s10787-024-01605-w. Epub 2024 Nov 26.
3
Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders.
抗抑郁药衍生物合成的最新进展:情绪障碍的药理学见解
3 Biotech. 2024 Nov;14(11):260. doi: 10.1007/s13205-024-04104-5. Epub 2024 Oct 5.
4
A new crystalline daidzein-piperazine salt with enhanced solubility, permeability, and bioavailability.一种具有增强的溶解性、渗透性和生物利用度的新型结晶大豆苷元-哌嗪盐。
Front Pharmacol. 2024 Jul 22;15:1385637. doi: 10.3389/fphar.2024.1385637. eCollection 2024.
5
Parallel Synthesis of Piperazine Tethered Thiazole Compounds with Antiplasmodial Activity.具有抗疟活性的哌嗪连接噻唑类化合物的平行合成。
Int J Mol Sci. 2023 Dec 12;24(24):17414. doi: 10.3390/ijms242417414.
6
Effect of the isotiazole adjuvants in combination with cisplatin in chemotherapy of neuroepithelial tumors: experimental results and modeling.异噻唑增效剂联合顺铂化疗神经上皮肿瘤的效果:实验结果与建模。
Sci Rep. 2023 Aug 21;13(1):13624. doi: 10.1038/s41598-023-40094-9.
7
Heterocyclic Merging of Stereochemically Diverse Chiral Piperazines and Morpholines with Indazoles.立体化学多样的手性哌嗪和吗啉与吲唑的杂环合并
Chemistry. 2023 Oct 2;29(55):e202301888. doi: 10.1002/chem.202301888. Epub 2023 Aug 29.
8
Comparison of In Vitro Antimelanoma and Antimicrobial Activity of 2,3-Indolo-betulinic Acid and Its Glycine Conjugates.2,3-吲哚桦木酸及其甘氨酸缀合物的体外抗黑色素瘤和抗菌活性比较
Plants (Basel). 2023 Mar 9;12(6):1253. doi: 10.3390/plants12061253.
9
Quinazolinone-based hybrids with diverse biological activities: A mini-review.具有多种生物活性的喹唑啉酮类杂化物:一篇综述。
J Res Med Sci. 2022 Sep 27;27:68. doi: 10.4103/jrms.jrms_1025_21. eCollection 2022.
10
NMR-based investigations of acyl-functionalized piperazines concerning their conformational behavior in solution.基于核磁共振的酰基官能化哌嗪在溶液中构象行为的研究。
RSC Adv. 2018 Dec 6;8(71):40921-40933. doi: 10.1039/c8ra09152h. eCollection 2018 Dec 4.